| 0 |
ANTERIOR CAPSULAR RUPTURE |
1 |
0.1250 |
| 1 |
HEPATOBILIARY PROCEDURAL COMPLICATION |
1 |
0.0357 |
| 2 |
PHOTOCOAGULATION |
1 |
0.0345 |
| 3 |
VAGINAL OPERATION |
2 |
0.0238 |
| 4 |
HAEMANGIOMA CONGENITAL |
8 |
0.0168 |
| 5 |
POLYPOIDAL CHOROIDAL VASCULOPATHY |
5 |
0.0161 |
| 6 |
LYMPHATIC OBSTRUCTION |
1 |
0.0116 |
| 7 |
DEVICE EXTRUSION |
2 |
0.0094 |
| 8 |
SYMBLEPHARON |
2 |
0.0077 |
| 9 |
FOETAL ANAEMIA |
1 |
0.0076 |
| 10 |
RETINAL SCAR |
3 |
0.0065 |
| 11 |
SUBRETINAL FIBROSIS |
1 |
0.0051 |
| 12 |
CHOROIDAL NEOVASCULARISATION |
4 |
0.0047 |
| 13 |
POSTOPERATIVE FEVER |
1 |
0.0036 |
| 14 |
DEVICE COMPUTER ISSUE |
1 |
0.0033 |
| 15 |
RETINAL DEPIGMENTATION |
1 |
0.0033 |
| 16 |
RETINAL INJURY |
2 |
0.0026 |
| 17 |
GLIOSIS |
1 |
0.0023 |
| 18 |
CONTRAST MEDIA ALLERGY |
4 |
0.0022 |
| 19 |
PATENT DUCTUS ARTERIOSUS |
8 |
0.0020 |
| 20 |
PROTEIN-LOSING GASTROENTEROPATHY |
1 |
0.0020 |
| 21 |
AGE-RELATED MACULAR DEGENERATION |
3 |
0.0020 |
| 22 |
CHOROIDAL DETACHMENT |
1 |
0.0018 |
| 23 |
PROTRUSION TONGUE |
1 |
0.0017 |
| 24 |
RETINAL VASCULAR DISORDER |
1 |
0.0017 |
| 25 |
RETINAL ISCHAEMIA |
1 |
0.0016 |
| 26 |
TONGUE PARALYSIS |
1 |
0.0014 |
| 27 |
OPTIC NERVE DISORDER |
2 |
0.0012 |
| 28 |
PROCEDURAL HYPOTENSION |
1 |
0.0012 |
| 29 |
DETACHMENT OF RETINAL PIGMENT EPITHELIUM |
1 |
0.0011 |
| 30 |
VITREOUS HAEMORRHAGE |
3 |
0.0011 |
| 31 |
RETINAL EXUDATES |
1 |
0.0011 |
| 32 |
LOW BIRTH WEIGHT BABY |
8 |
0.0010 |
| 33 |
RETINAL TOXICITY |
1 |
0.0010 |
| 34 |
SUBRETINAL FLUID |
1 |
0.0009 |
| 35 |
RETINAL DEGENERATION |
1 |
0.0008 |
| 36 |
RETINAL DISORDER |
2 |
0.0008 |
| 37 |
CONTRAINDICATION TO MEDICAL TREATMENT |
1 |
0.0007 |
| 38 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 39 |
RETINAL HAEMORRHAGE |
4 |
0.0006 |
| 40 |
LARYNGEAL OEDEMA |
3 |
0.0005 |
| 41 |
QUADRIPLEGIA |
1 |
0.0005 |
| 42 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
1 |
0.0004 |
| 43 |
LIVER FUNCTION TEST INCREASED |
7 |
0.0003 |
| 44 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 45 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 46 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 47 |
VISUAL FIELD DEFECT |
2 |
0.0003 |
| 48 |
VISUAL ACUITY REDUCED |
7 |
0.0002 |
| 49 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 50 |
FOETAL DEATH |
1 |
0.0002 |
| 51 |
CYST |
2 |
0.0002 |
| 52 |
SWOLLEN TONGUE |
5 |
0.0002 |
| 53 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 54 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 55 |
DEVICE INFORMATION OUTPUT ISSUE |
1 |
0.0001 |
| 56 |
ANAPHYLACTIC SHOCK |
3 |
0.0001 |
| 57 |
HYSTERECTOMY |
1 |
0.0001 |
| 58 |
SKIN SWELLING |
1 |
0.0001 |
| 59 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 60 |
CHOLESTASIS |
2 |
0.0001 |
| 61 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 62 |
PALPITATIONS |
10 |
0.0001 |
| 63 |
DRUG TOXICITY |
1 |
0.0001 |
| 64 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 65 |
PARALYSIS |
1 |
0.0001 |
| 66 |
TACHYCARDIA |
6 |
0.0001 |
| 67 |
DISEASE PROGRESSION |
7 |
0.0001 |
| 68 |
URTICARIA |
9 |
0.0001 |
| 69 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 70 |
CATARACT |
3 |
0.0001 |
| 71 |
FOETAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 72 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 73 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 74 |
MATERNAL EXPOSURE DURING PREGNANCY |
4 |
0.0000 |
| 75 |
THROMBOCYTOPENIA |
5 |
0.0000 |
| 76 |
SNEEZING |
1 |
0.0000 |
| 77 |
THROAT IRRITATION |
2 |
0.0000 |
| 78 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 79 |
CHROMATURIA |
1 |
0.0000 |
| 80 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 81 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 82 |
DRUG RESISTANCE |
1 |
0.0000 |
| 83 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 84 |
FEAR |
1 |
0.0000 |
| 85 |
RASH PRURITIC |
2 |
0.0000 |
| 86 |
ASCITES |
1 |
0.0000 |
| 87 |
RENAL INJURY |
1 |
0.0000 |
| 88 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 89 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 90 |
HYPOTENSION |
6 |
0.0000 |
| 91 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 92 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 93 |
EYE SWELLING |
1 |
0.0000 |
| 94 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 95 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 96 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 97 |
PARAESTHESIA |
4 |
0.0000 |
| 98 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 99 |
CARDIAC ARREST |
2 |
0.0000 |
| 100 |
HYPOACUSIS |
1 |
0.0000 |
| 101 |
LIVER DISORDER |
1 |
0.0000 |
| 102 |
HYPOAESTHESIA |
3 |
0.0000 |
| 103 |
SYNCOPE |
2 |
0.0000 |
| 104 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 105 |
MEDICATION ERROR |
1 |
0.0000 |
| 106 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 107 |
LETHARGY |
1 |
0.0000 |
| 108 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 109 |
PRURITUS |
6 |
0.0000 |
| 110 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 111 |
INJURY |
1 |
0.0000 |
| 112 |
DYSPNOEA |
8 |
0.0000 |
| 113 |
RASH |
6 |
0.0000 |
| 114 |
EPISTAXIS |
1 |
0.0000 |
| 115 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 116 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 117 |
CARDIAC FAILURE |
1 |
0.0000 |
| 118 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 119 |
PRODUCT USE IN UNAPPROVED INDICATION |
3 |
0.0000 |
| 120 |
DIZZINESS |
6 |
0.0000 |
| 121 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 122 |
COUGH |
3 |
0.0000 |
| 123 |
HEART RATE INCREASED |
1 |
0.0000 |
| 124 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 125 |
BACK PAIN |
2 |
0.0000 |
| 126 |
CHILLS |
1 |
0.0000 |
| 127 |
VOMITING |
4 |
0.0000 |
| 128 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 129 |
OFF LABEL USE |
7 |
0.0000 |
| 130 |
HYPERHIDROSIS |
1 |
0.0000 |
| 131 |
NAUSEA |
6 |
0.0000 |
| 132 |
RENAL FAILURE |
1 |
0.0000 |
| 133 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 134 |
ANXIETY |
2 |
0.0000 |
| 135 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 136 |
DRUG INTERACTION |
1 |
0.0000 |
| 137 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 138 |
PYREXIA |
2 |
0.0000 |
| 139 |
ASTHENIA |
2 |
0.0000 |
| 140 |
ANAEMIA |
1 |
0.0000 |
| 141 |
ERYTHEMA |
1 |
0.0000 |
| 142 |
HYPERTENSION |
1 |
0.0000 |
| 143 |
DRUG INEFFECTIVE |
6 |
0.0000 |
| 144 |
DEPRESSION |
1 |
0.0000 |
| 145 |
PAIN |
1 |
0.0000 |
| 146 |
FATIGUE |
1 |
0.0000 |
| 147 |
DEATH |
1 |
0.0000 |